In experimental rat models of focal cerebral ischemia, the CKLF1 antagonist C19 peptide has demonstrated efficacy in reversing CKLF1-mediated cerebral ischemia, as evidenced by reductions in infarct size and cerebral water content (Kong et al., 2012). The gene discussed is CKLF; the disease is brain ischemia.